Conversion therapy with chemoimmunotherapy induced pCR in a stage IV lung squamous cell carcinoma patient harboring EGFR exon 20 insertion

This case study details an innovative conversion therapy strategy in a 58-year-old Asian male with baseline stage cT4N1M1b advanced lung squamous cell carcinoma (SCC) harboring a rare EGFR exon 20 insertion mutation with concurrent high PD-L1 expression who achieved a pathologic complete response (p...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mingjin Xu, Xingfa Huo, Chuantao Zhang, Xuchen Zhang, Huiyun Wang, Hongmin Yang, Nan Ge, Yongjie Wang, Helei Hou
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	Human Vaccines & Immunotherapeutics
Subjects:	Conversion therapy EGFR exon 20 inserted non-small cell lung cancer immune checkpoint blockade pathological complete response case report
Online Access:	https://www.tandfonline.com/doi/10.1080/21645515.2024.2431384
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Conversion therapy with chemoimmunotherapy induced pCR in a stage IV lung squamous cell carcinoma patient harboring EGFR exon 20 insertion

Similar Items